CIK 0001752828 · <br>Emerging growth company
Celularity Inc
Sign in to watch- Ticker
- CELU
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831702591
- Phone
- (908) 768-2170
- Business address
- 170 PARK AVE, FLORHAM PARK, NJ, 07932
- Former names
- GX Acquisition Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-16 | Hariri Robert J Chief Executive Officer | Other acquisition | +7,734,689 | 7,734,689 | ||
| 2021-07-16 | Hariri Robert J Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +349,360 | 349,360 | ||
| 2021-07-16 | Hariri Robert J Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +174,680 | 174,680 | ||
| 2021-07-16 | Hariri Robert J Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +384,297 | 384,297 | ||
| 2021-07-16 | Hariri Robert J Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +1,921,485 | 1,921,485 | ||
| 2021-07-16 | Lim Kok Thay Director | Grant or award | +26,562,778 | 26,562,778 | ||
| 2021-07-16 | Lim Kok Thay Director | Grant or award | +3,500,000 | $10.00 | $35.0M | 30,062,778 |
| 2021-07-16 | Lim Kok Thay Director | Grant or award · Warrants (Right to Buy) | +6,529,818 | 6,529,818 | ||
| 2021-07-16 | Lim Kok Thay Director | Grant or award · Deferred Compensation Award (Right to Buy) | +269,007 | 269,007 | ||
| 2021-07-16 | Dunn Keary General Counsel & Business Dev | Grant or award · Stock Option (Right to Buy) | +384,297 | 384,297 | ||
| 2021-07-16 | Brigido Stephen Pres, Functional Regeneration | Grant or award · Stock Option (Right to Buy) | +20,379 | 20,379 | ||
| 2021-07-16 | Brigido Stephen Pres, Functional Regeneration | Grant or award · Stock Option (Right to Buy) | +153,718 | 153,718 | ||
| 2021-07-16 | Brigido Stephen Pres, Functional Regeneration | Grant or award · Stock Option (Right to Buy) | +76,859 | 76,859 | ||
| 2021-07-16 | Dunn Keary General Counsel & Business Dev | Grant or award · Stock Option (Right to Buy) | +105,207 | 105,207 | ||
| 2021-07-16 | Dunn Keary General Counsel & Business Dev | Grant or award · Stock Option (Right to Buy) | +279,089 | 279,089 | ||
| 2021-07-16 | Brigido Stephen Pres, Functional Regeneration | Grant or award · Stock Option (Right to Buy) | +20,379 | 20,379 | ||
| 2021-07-16 | Brigido Stephen Pres, Functional Regeneration | Grant or award · Stock Option (Right to Buy) | +87,872 | 87,872 | ||
| 2021-07-16 | Brigido Stephen Pres, Functional Regeneration | Grant or award · Stock Option (Right to Buy) | +65,846 | 65,846 | ||
| 2021-07-16 | Brigido Stephen Pres, Functional Regeneration | Grant or award · Stock Option (Right to Buy) | +76,859 | 76,859 |
Page 15 of 15 · 299 trades